Exelixis drug improves overall survival in liver cancer patients Ruby Khatun Khatun21 Oct 2017 3:42 AM GMTExelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert...
Bayer, Johnson and Johnson in frame for bigger anti-clotting market opportunity Ruby Khatun Khatun28 Aug 2017 7:35 AM GMTFRANKFURT: Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and...
Delhi HC allows Natco, Alembic to Export Rivaroxaban of Bayer savita thakur thakur10 March 2017 4:15 AM GMTNEW DELHI: In a recent order passed by Delhi High Court, the court has granted the permission to Indian pharmaceuticals companies, Alembic and Natco...
Bayer applies for Regorafenib authorization to treat liver cancer supriya kashyap kashyap8 Nov 2016 6:26 AM GMTGerman drugmaker Bayer said it submitted an application to have its cancer drug Regorafenib approved for the second-line treatment of liver cancer...
